QIA.DE: Qiagen N.V. Stock Live Price Graph
About the company
QIAGEN N.V. delivers comprehensive "sample to insight" solutions globally, enabling the transformation of biological materials into valuable molecular insights. Their extensive product portfolio addresses various stages of molecular analysis, starting with primary sample technologies. This includes a range of consumables such as kits for nucleic acid stabilization and purification from initial biological samples, as well as manual and automated processing systems for applications like genotyping, gene expression, and viral or bacterial analysis, often utilizing advanced silica membrane and magnetic bead methodologies. They also supply components and kits for purifying nucleic acids from secondary sample types, alongside dedicated instruments and accessories for efficient nucleic acid purification. The company's broad suite of assays covers critical diagnostic and research areas. These include interferon-gamma release tests for tuberculosis, assays for post-transplant monitoring and viral load assessment, and solutions for prenatal testing, detection of sexually transmitted diseases, and human papillomavirus (HPV). Furthermore, QIAGEN provides assays for analyzing complex genomic variants, such as mutations, insertions, deletions, and fusions. For streamlined diagnostics, their "sample to insight" instruments facilitate one-step molecular analysis for challenging syndromes and integrate PCR testing capabilities. QIAGEN also develops and supplies an array of PCR consumables, including quantitative PCR, reverse transcription, and combination kits, essential for gene expression analysis, genotyping, and gene regulation studies. Their offerings extend to human identification and forensics, with STR assays and kits for food contamination detection. The company also features PCR instruments, including cutting-edge digital PCR solutions, and custom-developed OEM consumables. Further bolstering their capabilities, QIAGEN provides predefined and customizable Next-Generation Sequencing (NGS) gene panels, alongside library preparation kits, components, and whole genome amplification solutions. Complementing their vast selection of consumables and instruments, the company offers robust bioinformatics solutions and specialized custom laboratory and genomic services. Serving a diverse customer base, QIAGEN caters to molecular diagnostics laboratories, academic research institutions, pharmaceutical companies, and applied testing sectors. Strategic alliances are maintained with Sysmex Corporation, OncXerna Therapeutics, and Mirati. Founded in 1986, QIAGEN N.V. maintains its corporate headquarters in Venlo, the Netherlands.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $2.0774 | $2.0774 | 6.50% | - |
| - | $0.212 | $0.212 | 3.22% | - |
| - | $1.1099 | $1.1099 | 2.62% | - |
| - | $1.0962 | $1.0962 | 2.73% | - |
| - | $1.08 | $1.08 | 3.58% | - |
What Is QIA.DE? Live QIA.DE Prices and Analysis
QIA.DE, or Qiagen N.V., is a prominent global provider of sample and assay technologies, serving the healthcare sector through molecular diagnostics, applied testing, academic research, and pharmaceutical development. The company is crucial in the life sciences sector, offering products that facilitate the rapid and accurate analysis of biological samples. Investors closely monitor Qiagen due to its innovative solutions and its role in addressing health challenges, particularly in diagnostics and personalized medicine.
As a publicly traded company on the Frankfurt Stock Exchange, QIA.DE has garnered significant attention from investors interested in the biotech and healthcare sectors. The company’s performance is often viewed as a barometer for trends in life sciences, especially amidst evolving global health challenges.
Market Context
Qiagen operates within a dynamic international trading environment, with its pricing influenced by global demand for diagnostic solutions and healthcare innovations. The volatility in the biotech sector often reflects broader economic conditions, regulatory changes, and advancements in technology. Investors should note that QIA.DE is priced in Euros, which can introduce additional currency risk for investors operating in other currencies.
Why Do QIA.DE Prices Rise or Fall?
The price of QIA.DE shares is influenced by various factors that can lead to fluctuations in market sentiment and valuation. Understanding these factors can help investors make informed decisions.
- Earnings Reports: Quarterly and annual earnings can significantly impact investor sentiment.
- Product Developments: New product launches or advancements in existing technologies can drive interest.
- Market Trends: Overall trends in the biotech and healthcare sectors can influence stock performance.
- Regulatory Changes: New regulations or approvals can impact operational capabilities and market access.
- Economic Conditions: Broader economic indicators can affect investment decisions and market confidence.
- Competition: The emergence of new competitors or technologies can affect market share and pricing strategies.
- Investor Sentiment: Market perception and analyst ratings can lead to rapid price changes.
- Global Health Events: Situations like pandemics can create sudden spikes in demand for diagnostic products.
In summary, QIA.DE prices are subject to a range of influences that can cause volatility. Investors should stay informed about these factors to better anticipate potential price movements.
Why Is Live QIA.DE Price Tracking Important?
Tracking the live price of QIA.DE is crucial for investors looking to capitalize on market opportunities. Real-time data allows investors to make timely decisions based on current market conditions.
- Immediate Response: Investors can react to price changes quickly.
- Market Trends: Live tracking helps identify upward or downward trends.
- Investment Timing: Knowing the latest price can aid in timing buy or sell decisions.
- Portfolio Management: Real-time data assists in managing investment portfolios effectively.
- Risk Management: Investors can set stop-loss orders based on live prices to mitigate risks.
What Should You Consider When Trading / Investing in QIA.DE?
Investing in QIA.DE can present opportunities, but it is essential to consider various factors that may impact your investment.
- Market Volatility: Biotech stocks can be highly volatile, leading to rapid price changes.
- Risk Tolerance: Assess your risk tolerance before investing, particularly in a dynamic sector.
- Macro Data: Keep an eye on economic indicators that may affect the healthcare sector.
- Regulatory Environment: Changes in regulations can impact company operations and profitability.
- Earnings Trends: Analyze earnings reports to understand the company’s financial health.
What Can You Find on the Investvio QIA.DE Page?
- Live price updates and historical price charts.
- Technical analysis tools for informed trading decisions.
- Latest news and updates affecting QIA.DE.
- Earnings reports and dividend announcements.
- Market sentiment indicators and analyst ratings.
Investors can leverage the comprehensive data available on the Investvio QIA.DE page to make informed trading and investment decisions, ensuring they stay ahead in the competitive biotech landscape.